Aliases & Classifications for Oligohydramnios

MalaCards integrated aliases for Oligohydramnios:

Name: Oligohydramnios 12 29 54 6 43 15 17 71 32
Oligohydramnios - Delivered 12 71
Oligohydramnios, Antepartum Condition or Complication 71
Antepartum Oligohydramnios 12
Delivered Oligohydramnios 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12215
ICD9CM 34 658.0
MeSH 43 D016104
NCIt 49 C92839
SNOMED-CT 67 59566000
ICD10 32 O41.0
UMLS 71 C0079924 C0157142 C0157143

Summaries for Oligohydramnios

Disease Ontology : 12 A placenta disease that is characterized by a deficiency of amniotic fluid sometimes resulting in an embryonic defect through adherence between embryo and amnion.

MalaCards based summary : Oligohydramnios, also known as oligohydramnios - delivered, is related to potter's syndrome and renal tubular dysgenesis, and has symptoms including morning sickness An important gene associated with Oligohydramnios is PKHD1 (PKHD1 Ciliary IPT Domain Containing Fibrocystin/Polyductin), and among its related pathways/superpathways are Oxytocin signaling pathway and AGE-RAGE signaling pathway in diabetic complications. The drugs Warfarin and Coumarin have been mentioned in the context of this disorder. Affiliated tissues include lung, kidney and placenta, and related phenotypes are behavior/neurological and cardiovascular system

Wikipedia : 74 Oligohydramnios is a condition in pregnancy characterized by a deficiency of amniotic fluid. It is the... more...

Related Diseases for Oligohydramnios

Diseases related to Oligohydramnios via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 279, show less)
# Related Disease Score Top Affiliating Genes
1 potter's syndrome 34.3 REN PKHD1 AGT ACE
2 renal tubular dysgenesis 33.7 REN AGTR1 AGT ACE
3 polycystic kidney disease 4 with or without polycystic liver disease 33.2 TMEM67 PKHD1 CC2D2A
4 multiple pterygium syndrome, lethal type 32.6 CHRNG CHRND CHRNA1
5 urinary tract obstruction 31.5 REN AQP1 AGTR1 ACE
6 renal dysplasia 31.4 REN AGTR1 AGT ACE
7 anuria 31.4 REN AGTR1 AGT ACE
8 posterior urethral valves 31.4 AGTR1 AGT ACE
9 polyhydramnios 31.3 REN OXT NPPB EDN1 AQP3 AQP1
10 respiratory failure 31.1 REN NPPB EDN1 ACE
11 pulmonary hypertension 31.1 REN NPPB EDN1 AGTR1 ACE
12 vesicoureteral reflux 1 31.0 REN AGTR1 AGT ACE
13 pre-eclampsia 31.0 REN OXT EDN1 AGTR1 AGT AFP
14 eclampsia 30.9 REN OXT EDN1 AGT ACE
15 diabetes insipidus 30.9 REN OXT AQP3 AFP
16 placenta praevia 30.8 OXT CHRND
17 polycystic kidney disease 30.8 TMEM67 REN PKHD1 EDN1 AQP1 AGTR1
18 placenta disease 30.8 OXT MIR517A AFP
19 end stage renal disease 30.8 REN INF2 AGTR1 AGT ACE
20 microvascular complications of diabetes 3 30.7 REN AGTR1 ACE
21 cystic lymphangioma 30.6 CHRNG CHRND CHRNA1 AFP
22 patent ductus arteriosus 1 30.6 REN NPPB EDN1 ACE
23 kidney disease 30.5 TMEM67 REN PKHD1 NPPB EDN1 AGTR1
24 pulmonary edema 30.2 REN OXT NPPB EDN1 AGTR1 AGT
25 autosomal dominant polycystic kidney disease 30.2 REN PKHD1 EDN1 AQP3 AQP1 AGTR1
26 renal hypodysplasia/aplasia 1 11.5
27 trisomy 2 mosaicism 11.5
28 meckel syndrome, type 1 11.5
29 twin-to-twin transfusion syndrome 11.5
30 severe pre-eclampsia 11.5
31 bilateral renal agenesis dominant type 11.4
32 situs inversus totalis with cystic dysplasia of kidneys and pancreas 11.2
33 urethral obstruction sequence 11.2
34 congenital anomalies of kidney and urinary tract 2 11.1
35 renal dysplasia-limb defects syndrome 11.1
36 meckel syndrome, type 7 11.1
37 fetal indomethacin syndrome 11.1
38 malignant secondary hypertension 10.7 REN AGTR1
39 hypoaldosteronism 10.7 REN ACE
40 renal artery obstruction 10.7 REN ACE
41 microphthalmia, isolated 1 10.7 CHRNG CHRND
42 orthostatic proteinuria 10.7 REN ACE
43 hypertensive encephalopathy 10.7 REN AGTR1 ACE
44 hypertensive retinopathy 10.7 REN AGTR1 ACE
45 hypertension, diastolic 10.7 REN ACE
46 cardiac tuberculosis 10.7 NPPB ACE
47 familial hypertension 10.7 REN AGTR1 AGT
48 polycystic kidney disease 4 10.7 PKHD1 NPPB
49 meningococcal infection 10.6 AGTR1 AGT
50 slow-channel congenital myasthenic syndrome 10.6 CHRND CHRNA1
51 cholesterol embolism 10.6 REN ACE
52 toxic myocarditis 10.6 NPPB ACE
53 malignant renovascular hypertension 10.6 REN EDN1 AGTR1
54 iga nephropathy 1 10.6 AGTR1 ACE
55 acute mountain sickness 10.6 EDN1 AGTR1 ACE
56 left bundle branch hemiblock 10.6 REN NPPB ACE
57 anterolateral myocardial infarction 10.6 NPPB ACE
58 fibromuscular dysplasia 10.6 REN AGTR1 AGT ACE
59 hydrarthrosis 10.6 AQP3 AQP1
60 obstructive nephropathy 10.6 REN AGT ACE
61 central sleep apnea 10.6 REN NPPB ACE
62 raynaud disease 10.6 EDN1 AGTR1 ACE
63 renal artery disease 10.6 REN AGTR1 AGT ACE
64 cardiac tamponade 10.6 REN NPPB ACE
65 nephronophthisis 2 10.6 TMEM67 PKHD1 CC2D2A
66 aortic valve insufficiency 10.6 REN NPPB ACE
67 neuromuscular junction disease 10.6 CHRNG CHRND CHRNA1
68 mitral valve stenosis 10.6 REN NPPB ACE
69 myocardial stunning 10.6 EDN1 AGTR1 ACE
70 mitral valve insufficiency 10.6 REN NPPB ACE
71 iga glomerulonephritis 10.6 REN AGTR1 AGT ACE
72 chronic thromboembolic pulmonary hypertension 10.6 NPPB EDN1
73 pericardium disease 10.6 REN NPPB ACE
74 interstitial nephritis 10.6 REN AGTR1 AGT ACE
75 kidney papillary necrosis 10.6 REN ACE
76 congenital hepatic fibrosis 10.6 TMEM67 PKHD1 CC2D2A AGTR1
77 pericardial effusion 10.6 REN NPPB ACE
78 ureteral disease 10.6 REN AQP1 AGTR1 ACE
79 generalized atherosclerosis 10.6 REN ACE
80 pulmonary valve insufficiency 10.6 NPPB EDN1 ACE
81 myasthenic syndrome, congenital, 1a, slow-channel 10.6 OXT CHRND CHRNA1
82 nonarteritic anterior ischemic optic neuropathy 10.6 EDN1 AGTR1 ACE
83 joubert syndrome 6 10.6 TMEM67 CC2D2A
84 extrinsic cardiomyopathy 10.6 REN NPPB ACE
85 sleep disorder 10.6 REN EDN1 ACE
86 chronic pulmonary heart disease 10.6 NPPB EDN1 ACE
87 multiple pterygium syndrome, escobar variant 10.6 CHRNG CHRND CHRNA1
88 heart conduction disease 10.6 REN NPPB ACE
89 severe nonproliferative diabetic retinopathy 10.6 REN ACE
90 angina pectoris 10.6 NPPB EDN1 ACE
91 vein disease 10.6 EDN1 AFP ACE
92 retinal vascular disease 10.6 REN EDN1 ACE
93 portal hypertension 10.6 PKHD1 EDN1 AGTR1 ACE
94 hepatic vascular disease 10.6 REN PKHD1 EDN1 AFP
95 aortic valve disease 2 10.5 REN NPPB AGT ACE
96 otosclerosis 10.5 AGTR1 AGT ACE
97 coach syndrome 10.5 TMEM67 CC2D2A AFP ACE
98 polycystic kidney disease 1 with or without polycystic liver disease 10.5 REN PKHD1 ACE
99 tricuspid valve insufficiency 10.5 REN NPPB EDN1 ACE
100 tricuspid valve disease 10.5 REN NPPB EDN1 ACE
101 encephalocele 10.5 TMEM67 CC2D2A
102 heart valve disease 10.5 REN NPPB ACE
103 sexual disorder 10.5 OXT EDN1 ACE
104 cystic kidney disease 10.5 TMEM67 REN PKHD1 CC2D2A ACE
105 intrinsic cardiomyopathy 10.5 REN NPPB ACE
106 peripheral artery disease 10.5 NPPB EDN1 ACE
107 systolic heart failure 10.5 NPPB EDN1 AGT ACE
108 polycystic liver disease 10.5 TMEM67 PKHD1 AQP1
109 idiopathic edema 10.5 NPPB EDN1 AQP1 ACE
110 impotence 10.5 OXT EDN1 ACE
111 joubert syndrome 10 10.5 TMEM67 CC2D2A
112 first-degree atrioventricular block 10.5 NPPB ACE
113 diastolic heart failure 10.5 REN NPPB AGTR1 AGT ACE
114 orthostatic intolerance 10.5 REN PKHD1 EDN1 AGTR1 ACE
115 hypertensive heart disease 10.5 REN NPPB AGTR1 AGT ACE
116 mitral valve disease 10.5 REN NPPB AGTR1 AGT ACE
117 chronic mountain sickness 10.5 NPPB EDN1
118 patent foramen ovale 10.5 REN NPPB EDN1 ACE
119 coronary heart disease 1 10.5 NPPB EDN1 AGTR1 ACE
120 diabetes insipidus, nephrogenic, autosomal 10.5 REN OXT AQP3 AQP1
121 kidney hypertrophy 10.5 REN ACE
122 cerebrovascular disease 10.5 REN NPPB AGTR1 AGT ACE
123 atrial fibrillation 10.5 REN NPPB AGTR1 AGT ACE
124 apnea, obstructive sleep 10.5 REN NPPB EDN1 AGT ACE
125 renovascular hypertension 10.5 REN NPPB EDN1 AGTR1 ACE
126 preterm premature rupture of the membranes 10.5
127 hepatorenal syndrome 10.5 REN EDN1 AQP1 AFP ACE
128 sleep apnea 10.5 REN NPPB EDN1 AGT ACE
129 cardiac arrest 10.5 REN OXT NPPB ACE
130 plantar fascial fibromatosis 10.5 AGTR1 AGT
131 neuromuscular disease 10.5 INF2 CHRNG CHRND CHRNA1
132 stroke, ischemic 10.5 REN NPPB AGTR1 AGT ACE
133 lipoprotein quantitative trait locus 10.5 REN NPPB EDN1 AGTR1 ACE
134 acute myocardial infarction 10.5 REN NPPB EDN1 AGTR1 ACE
135 hypertensive nephropathy 10.5 AGTR1 ACE
136 arteries, anomalies of 10.4 REN MIR517A EDN1 AGTR1 ACE
137 malignant hypertension 10.4 REN NPPB EDN1 AGTR1 AGT ACE
138 renal hypertension 10.4 REN NPPB EDN1 AGTR1 AGT ACE
139 migraine with or without aura 1 10.4 REN OXT EDN1 ACE
140 inappropriate adh syndrome 10.4 REN OXT NPPB AQP3 AQP1
141 aortic valve disease 1 10.4 REN EDN1 AGTR1 ACE
142 congestive heart failure 10.4 REN NPPB EDN1 AGTR1 AGT ACE
143 migraine with aura 10.4 EDN1 AQP1 ACE
144 vascular disease 10.4 REN NPPB EDN1 AGTR1 AGT ACE
145 tetralogy of fallot 10.4 REN NPPB EDN1 ACE
146 cardiovascular system disease 10.4 REN NPPB EDN1 AGTR1 AGT ACE
147 myocardial infarction 10.4 REN NPPB EDN1 AGTR1 AGT ACE
148 atrial heart septal defect 10.4 NPPB EDN1 ACE
149 hypertrophic cardiomyopathy 10.4 REN NPPB EDN1 AGTR1 AGT ACE
150 renal fibrosis 10.4 REN AGTR1 AGT
151 chorioamnionitis 10.4
152 hydronephrosis 10.3
153 postsynaptic congenital myasthenic syndromes 10.3 CHRND CHRNA1
154 microvascular complications of diabetes 5 10.3 AGTR1 AGT ACE
155 chronic kidney disease 10.3 REN NPPB INF2 EDN1 AGTR1 AGT
156 placental insufficiency 10.3
157 placental abruption 10.3
158 endometritis 10.3
159 meconium aspiration syndrome 10.3
160 cleft palate, isolated 10.2
161 constrictive pericarditis 10.2 NPPB ACE
162 clubfoot 10.2
163 pneumothorax 10.2
164 chromosomal triplication 10.2
165 dilated cardiomyopathy 10.2 REN NPPB EDN1 AGTR1 AGT ACE
166 gastroschisis 10.2
167 cerebral palsy 10.2
168 abdominal wall defect 10.2
169 myasthenic syndrome, congenital, 13 10.1 CHRND CHRNA1
170 diaphragmatic hernia, congenital 10.1
171 enterocolitis 10.1
172 hydrops fetalis, nonimmune 10.1
173 alkuraya-kucinskas syndrome 10.1
174 renal hypoplasia 10.1
175 47,xyy 10.1
176 cytomegalovirus infection 10.1
177 atresia of urethra 10.1
178 congenital amyoplasia 10.1
179 hypertension, essential 10.1 REN OXT NPPB MIR517A INF2 EDN1
180 prune belly syndrome 10.0
181 neural tube defects 10.0
182 chromosome 2q35 duplication syndrome 10.0
183 torticollis 10.0
184 vater/vacterl association 10.0
185 wolf-hirschhorn syndrome 10.0
186 fetal akinesia deformation sequence 1 10.0
187 polydactyly 10.0
188 malaria 10.0
189 autosomal recessive disease 10.0
190 cakut 10.0
191 asphyxia neonatorum 10.0
192 gestational diabetes 10.0
193 periventricular leukomalacia 10.0
194 vacterl association 10.0
195 ventricular septal defect 10.0
196 heart septal defect 10.0
197 thrombophilia 10.0
198 bilirubin metabolic disorder 10.0
199 acute kidney failure 10.0
200 bronchopulmonary dysplasia 10.0
201 chromosome 4p deletion 10.0
202 congenital cytomegalovirus 10.0
203 sirenomelia 10.0
204 autoimmune disease 9.9
205 cornelia de lange syndrome 1 9.9
206 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 9.9
207 exudative vitreoretinopathy 1 9.9
208 developmental dysplasia of the hip 1 9.9
209 larsen syndrome 9.9
210 pulmonary hypertension, primary, 1 9.9
211 split-hand/foot malformation 1 9.9
212 tracheoesophageal fistula with or without esophageal atresia 9.9
213 down syndrome 9.9
214 anus, imperforate 9.9
215 atrioventricular dissociation 9.9
216 cerebrooculofacioskeletal syndrome 1 9.9
217 fraser syndrome 1 9.9
218 hydrocephalus, congenital, 1 9.9
219 pierre robin syndrome 9.9
220 fryns microphthalmia syndrome 9.9
221 microvascular complications of diabetes 4 9.9
222 microvascular complications of diabetes 6 9.9
223 microvascular complications of diabetes 7 9.9
224 cyanosis, transient neonatal 9.9
225 short-rib thoracic dysplasia 10 with or without polydactyly 9.9
226 funisitis 9.9
227 adrenal cortical adenoma 9.9
228 pervasive developmental disorder 9.9
229 lymphoproliferative syndrome 9.9
230 hypoplastic right heart syndrome 9.9
231 nephroma 9.9
232 esophageal atresia 9.9
233 hypospadias 9.9
234 hydrocephalus 9.9
235 megacolon 9.9
236 patau syndrome 9.9
237 cornelia de lange syndrome 9.9
238 nephrotic syndrome 9.9
239 leiomyoma 9.9
240 newborn respiratory distress syndrome 9.9
241 plasmodium vivax malaria 9.9
242 persistent fetal circulation syndrome 9.9
243 bladder neck obstruction 9.9
244 plasmodium falciparum malaria 9.9
245 generalized anxiety disorder 9.9
246 ectodermal dysplasia 9.9
247 cutis laxa 9.9
248 teratoma 9.9
249 pseudohermaphroditism 9.9
250 myopathy 9.9
251 myofibroma 9.9
252 holoprosencephaly 9.9
253 congenital mesoblastic nephroma 9.9
254 movement disease 9.9
255 infertility 9.9
256 severe combined immunodeficiency 9.9
257 adenoma 9.9
258 juvenile rheumatoid arthritis 9.9
259 b-cell lymphoma 9.9
260 lung disease 9.9
261 perinatal necrotizing enterocolitis 9.9
262 neurofibromatosis 9.9
263 cleft lip 9.9
264 diabetes mellitus 9.9
265 hypoglycemia 9.9
266 congenital contractures 9.9
267 congenital torticollis 9.9
268 skeletal dysplasias 9.9
269 triploidy 9.9
270 uniparental disomy of chromosome 2 9.9
271 vacterl hydrocephaly 9.9
272 isolated pierre robin sequence 9.9
273 hypoxia 9.9
274 short rib-polydactyly syndrome 9.9
275 cleft lip/palate 9.9
276 epignathus 9.9
277 isolated split hand-split foot malformation 9.9
278 maternal uniparental disomy 9.9
279 maternal uniparental disomy of chromosome 2 9.9

Graphical network of the top 20 diseases related to Oligohydramnios:



Diseases related to Oligohydramnios

Symptoms & Phenotypes for Oligohydramnios

UMLS symptoms related to Oligohydramnios:


morning sickness

MGI Mouse Phenotypes related to Oligohydramnios:

45 (showing 6, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.18 ACE AFP AGT AGTR1 AQP1 AQP3
2 cardiovascular system MP:0005385 10.13 ACE AGT AGTR1 AQP1 AQP3 CC2D2A
3 growth/size/body region MP:0005378 10.07 ACE AGT AGTR1 AQP1 AQP3 CC2D2A
4 mortality/aging MP:0010768 10.03 ACE AFP AGT AGTR1 AQP1 AQP3
5 nervous system MP:0003631 9.73 AGT AGTR1 AQP1 CC2D2A CHRNA1 CHRNG
6 renal/urinary system MP:0005367 9.36 ACE AGT AGTR1 AQP1 AQP3 CC2D2A

Drugs & Therapeutics for Oligohydramnios

Drugs for Oligohydramnios (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 75, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Warfarin Approved Phase 4 81-81-2 6691 54678486
2
Coumarin Experimental Phase 4 91-64-5 323
3 Anticoagulants Phase 4
4 Coagulants Phase 4
5
Oxytocin Approved, Vet_approved Phase 3 50-56-6 53477758 439302
6
Dinoprostone Approved Phase 3 363-24-6 5280360
7
AT-101 Approved, Investigational Phase 2, Phase 3 652-67-5, 90141-22-3 12597
8
Isosorbide Dinitrate Approved, Investigational Phase 2, Phase 3 87-33-2 6883
9
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
10
Enoxaparin Approved Phase 3 9005-49-6 772
11
Dalteparin Approved Phase 3 9005-49-6
12
Tinzaparin Approved Phase 3 9041-08-1, 9005-49-6 25244225
13
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
14 diuretics Phase 2, Phase 3
15 isosorbide-5-mononitrate Phase 2, Phase 3
16 Analgesics, Non-Narcotic Phase 3
17 Fibrinolytic Agents Phase 3
18 Acetylsalicylic acid lysinate Phase 3
19 Heparin, Low-Molecular-Weight Phase 3
20 Analgesics Phase 3
21 Antipyretics Phase 3
22 Cyclooxygenase Inhibitors Phase 3
23 Platelet Aggregation Inhibitors Phase 3
24 Antirheumatic Agents Phase 3
25 calcium heparin Phase 3
26 Anti-Inflammatory Agents Phase 3
27 Anti-Inflammatory Agents, Non-Steroidal Phase 3
28
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 2 437-38-7 3345
29 Rosuvastatin Calcium Phase 1, Phase 2 147098-20-2
30 Lipid Regulating Agents Phase 1, Phase 2
31 Hypolipidemic Agents Phase 1, Phase 2
32 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 1, Phase 2
33 Anticholesteremic Agents Phase 1, Phase 2
34 Antimetabolites Phase 1, Phase 2
35
Sodium citrate Approved, Investigational 68-04-2
36
Caffeine Approved 58-08-2 2519
37
Misoprostol Approved 59122-46-2 5282381
38
Nifedipine Approved 21829-25-4 4485
39
Indomethacin Approved, Investigational 53-86-1 3715
40
Magnesium Sulfate Approved, Investigational, Vet_approved 7487-88-9 24083
41
Tocopherol Approved, Investigational 1406-66-2, 54-28-4 14986
42
Progesterone Approved, Vet_approved 57-83-0 5994
43
Citric acid Approved, Nutraceutical, Vet_approved 77-92-9 311
44
Vitamin D3 Approved, Nutraceutical 67-97-0 5280795 6221
45
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
46
Vitamin E Approved, Nutraceutical, Vet_approved 59-02-9 14985
47 Tocotrienol Investigational 6829-55-6
48 Citrate
49 Phosphodiesterase 5 Inhibitors
50 Phosphodiesterase Inhibitors
51 Sildenafil Citrate 171599-83-0
52 Trace Elements
53 Micronutrients
54 Nutrients
55 Calciferol
56 Calcium, Dietary
57 Gastrointestinal Agents
58 Antacids
59 Anti-Ulcer Agents
60 Anti-Arrhythmia Agents
61 Tocolytic Agents
62 Anticonvulsants
63 calcium channel blockers
64 Vitamins
65 Omega 3 Fatty Acid
66 Tocopherols
67 Tocotrienols
68 Hormones
69 Hormone Antagonists
70 Progestins
71 Linoleate
72 Anesthetics
73 Pharmaceutical Solutions
74 Anesthetics, Local
75
Calcium Nutraceutical 7440-70-2 271

Interventional clinical trials:

(showing 52, show less)
# Name Status NCT ID Phase Drugs
1 Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial Completed NCT01990690 Phase 4 anti oxidant omega 3
2 a Randomized Clinical Trial Using Oral Anti Coagulant in the Management of Unexplained Oligohydramnios Completed NCT01569035 Phase 4 warfarin
3 A Multi-center Randomized, Double-blind, Placebo-controlled Study of Colla Corii Asini for the Treatment of Anemia in Pregnant Women With Thalassemia(Presenting the Syndrome of Blood Deficiency) Recruiting NCT03374111 Phase 4 Colla corii asini;a Simulate Agent of Colla corii asini granule
4 Open Randomized Trial Comparing Perinatal Outcome Following Expectant Management Versus Amnioinfusion in PPROM <25 Wks With Persistent Oligohydramnios Unknown status NCT00787163 Phase 3
5 Induction of Labor in Oligohydramnios - A Comparison Between Two Modes of Cervical Ripening for Patients With Oligohydramnios at Term Unknown status NCT00815542 Phase 3 prostaglandins E2
6 Randomized Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Unknown status NCT00127946 Phase 3
7 Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction Unknown status NCT02684305 Phase 3 Administration of Propess;Intravenous oxytocin infusion
8 Nitric Oxide Donors for Treatment of Isolated Oligohydramnios: A Pilot Study Completed NCT02712125 Phase 2, Phase 3 isosorbide mononitrate;Placebo
9 Propess® Versus Double Balloon for Cervical Ripening of Prolonged Pregnancies: a Randomised Controlled Trial Completed NCT02907060 Phase 3 Pharmacological cervical ripening
10 Low Molecular Weight Heparin, Enoxaparin, to Prevent Adverse Maternal and Perinatal Outcomes in Women With Previous Severe Preeclampsia at Less Than 34 Weeks' Gestation. A Prospective Randomized Trial Completed NCT00986765 Phase 3 Lovenox® (enoxaparin);Aspegic ® (Aspirin)
11 Inhaled Nitric Oxide For The Treatment Of Hypoxic Respiratory Failure With Pulmonary Hypertension In Preterm Infants Withdrawn NCT00922532 Phase 3 Inhaled Nitric Oxide;Placebo
12 Randomized Controlled Trial of Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract Obstructions Unknown status NCT01552824 Phase 2
13 Rosuvastatin Use in Order to Induce Preeclampsia Resolution in Severe Preeclampsia Cases up to 48 Hours Following Delivery Unknown status NCT02314286 Phase 1, Phase 2 Rosuvastatin;Placebo
14 Alterations of the Uteroplacental and Fetal Pulmonary Circulation in Patients With Severe Idiopathic Oligohydramnios Following Amnioinfusion Therapy in a Longitudinal Study Unknown status NCT01258725 Phase 1
15 Study to Compare 2 Minimally Invasive Fetal Neural Tube Defect Repair Techniques: Repair Using Durepair Patch vs. Repair Without Durepair Patch Recruiting NCT03794011 Phase 1
16 Minimally Invasive Fetal Neural Tube Defect Repair Study Active, not recruiting NCT02230072 Phase 1
17 Does the Amniotic Fluid Index Affect the Fetal Cardiac Performance? Unknown status NCT03277417
18 Third Trimester Fetal Renal Artery Doppler Indices in Borderline Idiopathic Isolated Oligohydramnios and Relationship Between Neonatal Outcomes Unknown status NCT02901340
19 Sildenafil Citrate Therapy for Oligohydramnios Unknown status NCT02372487 sildenafil citrate
20 Effect of Treatment of Vitamin D Deficiency During Pregnancy on Hypocalcemia Unknown status NCT02021864 vitamin D3 50,000 unit;prenatal multivitamin
21 Randomized Controlled Trial of Amniotic Fluid Index Compared Between After Upright and Left Lateral Decubitus Maternal Position Change Unknown status NCT03536689
22 Clinical Evaluation of PRO-MComplete as an Aid in Determination of Rupture of Fetal Membranes Unknown status NCT02369601
23 Cost-effectiveness of a Screening Strategy for Q Fever Among Pregnant Women in Risk Areas: a Clustered Randomized Controlled Trial Unknown status NCT01095328
24 A Randomized Controlled Study Comparing Cervical Foley Catheter, Vaginal Dinoprostone and a Combination of the Two Methods for Induction of Labor Unknown status NCT02815865 Dinoprostone
25 Open Spina Bifida Fetoscopic Repair Project Unknown status NCT03562286
26 Management of Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term; the Mode of Delivery and the Neonatal Outcomes Completed NCT02581774
27 The Effect of Coffee Consumption on Fetal Renal Artery Blood Flow and Amniotic Fluid Volume in the Third Trimester of Pregnancy Completed NCT03798275
28 Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks Completed NCT03703037
29 Perinatal Outcomes According to Amniotic Fluid Indez After Premature Rupture of Membranes. A Prospective Cohort Study. Completed NCT01538030
30 Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios Completed NCT00066976
31 TRANSCERVICAL FOLEY CATHETER (FOLEY) Versus INTRAVAGINAL MISOPROSTOL FOR CERVICAL RIPENING AND INDUCTION OF LABOR: A RANDOMIZED CLINICAL TRIAL. Completed NCT01140971 Misoprostol
32 A Simple Technique to Modify Maternal Uterine Artery Perfusion. Completed NCT01698957
33 Effects of Fetal Movement Counting - a Randomized Controlled Trial of an Unselected Population Completed NCT00513942
34 Functional Capacity After Computer Assisted Periacetabular Osteotomy in Patients With Hip Dysplasia Completed NCT02015247
35 Comparison Between Fetal Fibronectin (Ffn) vs Cervical Length in Patient With Unfavourable Cervix in Prediction of Successful Induction of Labor Completed NCT03925922
36 A Randomized Clinical Trial on Comparison of Early Versus Late Initiation of Feeding in Preterm Small for Gestation Infants Below 35 Weeks Gestation With Prenatal Absent or Reversal of End Diastolic Flow (AREDF) in Umbilical Artery Completed NCT01759615
37 Are Renal Artery Doppler Indices Different Between Monochorionic Diamniotic Twins With Twin-twin Transfusion Syndrome and Monochorionic Diamniotic Twins Without Twin-twin Transfusion Syndrome? Completed NCT03449823
38 Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours Completed NCT03086967
39 Tocolysis for Preterm Labor Completed NCT00811057 1 Magnesium Sulfate;Nifedipine;Indomethacin
40 The Pseudo-Oligohydramnios/Hidden Pocket Study: The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index Recruiting NCT03935607
41 Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation: a Randomised Controlled Trial Recruiting NCT04141189
42 Validation of the Standardized Prenatal Clinical Management of Fetuses With Lower Urinary Tract Obstruction (LUTO) Recruiting NCT02315521
43 The Effect of Omega 3 and Vaginal Progesterone on Birth Weight and Doppler Velocimetry of Idiopathic Asymmetrically Intrauterine Growth-restricted Fetuses Recruiting NCT04161989 omega-3 fatty acids;vaginal progesterone
44 Patient Registry for Women Diagnosed With Preterm Premature Rupture of Membranes or PPROM During Pregnancy Recruiting NCT02997345
45 Pulmonary Hypertension in Preterm Children Born at Gestational Age <30 Weeks: Prevalence, Risk Factors and Outcome Recruiting NCT02729844
46 Middle Cerebral and Umbilical Arteries Doppler Indices in Pregestational Diabetic Versus Normal Pregnancies and Their Values in Predicting Adverse Neonatal Outcome Recruiting NCT03915990
47 Renal Anhydramnios Fetal Therapy (RAFT) Trial Recruiting NCT03101891 Isotonic fluid
48 The Influence of Low Sodium Diet on an Amniotic Fluid Index in a Patient That Diagnosed With Oligohydramnios and Assigned for Conservative Management - a Randomized Controlled Trial Not yet recruiting NCT03815968
49 Antenatal and Intrapartum Risk Factors Associated With Neonatal Hypoxic Ischemic Encephalopathy Not yet recruiting NCT04364932
50 Magnetic Resonance Imaging Versus Four Dimensional Ultrasound in Detection of Central Nervous System Fetal Congenital Anomalies Not yet recruiting NCT03888794
51 Submersion Therapy for the Reversal of Oligohydramnios; A Non-invasive Gentle Approach Terminated NCT01682928 IV/Oral Hydration and Bedrest
52 Pilot Study-A Cost and Time Savings Comparison of Lamellar Body Count and FLM II Withdrawn NCT00613977

Search NIH Clinical Center for Oligohydramnios

Cochrane evidence based reviews: oligohydramnios

Genetic Tests for Oligohydramnios

Genetic tests related to Oligohydramnios:

# Genetic test Affiliating Genes
1 Oligohydramnios 29

Anatomical Context for Oligohydramnios

MalaCards organs/tissues related to Oligohydramnios:

40
Lung, Kidney, Placenta, Heart, Testes, Fetal Lung, Brain

Publications for Oligohydramnios

Articles related to Oligohydramnios:

(showing 2526, show less)
# Title Authors PMID Year
1
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. 61 54
17653738 2008
2
Abnormal fetal heart rate tracing patterns during the first stage of labor: effect on perinatal outcome. 54 61
11641667 2001
3
[Activity of N-b-D-acetylglucosaminidase molecular forms in amniotic fluid of tobacco smoking pregnant women with oligohydramnios or premature rupture of the membrane complications]. 61 54
10860257 2000
4
Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population. 54 61
9170469 1997
5
Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester? 61 54
8750291 1995
6
Maternal serum markers in second-trimester oligohydramnios. 54 61
7526364 1994
7
Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios. 54 61
1372972 1992
8
Amniotic fluid N-acetyl-beta-D-glucosaminidase activity and renal abnormalities. 61 54
1750765 1991
9
[Oligohydramnios in mid-term pregnancy: analysis of 182 cases]. 54 61
2027677 1991
10
Maternal and perinatal outcomes of induction of labor in oligohydramnios at term-a retrospective cohort study. 61
30394156 2020
11
Delivery mode and perinatal outcomes after diagnosis of oligohydramnios at term in China. 61
30486718 2020
12
Clinical predictors of chronic kidney disease in congenital lower urinary tract obstruction. 61
31197474 2020
13
Tübingen hip flexion splints for developmental dysplasia of the hip in infants aged 0-6 months. 61
32503452 2020
14
Utility of ultrasound assessment in management of pregnancies with preterm prelabor rupture of membranes. 61
31332850 2020
15
The impact of residual oligohydramnios following preterm premature rupture of membranes on adverse pregnancy outcomes: a meta-analysis. 61
32109463 2020
16
Pregnancy and delivery in women with a high risk of infection in pregnancy. 61
32576052 2020
17
Aquaporin 1 affects pregnancy outcome and regulates aquaporin 8 and 9 expressions in the placenta. 61
32542408 2020
18
Fetal left ventricular modified myocardial performance index and renal artery pulsatility index in pregnancies with isolated oligohydramnios before 37 weeks of gestation. 61
32517425 2020
19
Perinatal Outcome of Twin Pregnancies Complicated by Rupture of Membranes at 13-20 Weeks: Is Selective Termination an Appropriate Management Option? 61
32542619 2020
20
Prevention of perinatal complications in pregnant women with chronic papillomavirus infection. 61
32564038 2020
21
Perinatal and infant outcome in prenatally diagnosed hyperechogenic kidneys. 61
32530118 2020
22
Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network. 61
32228112 2020
23
[Ultrasonographic manifestation and genetic analysis of a fetus with nephronophthisis type 2]. 61
32335886 2020
24
Induction of labour indications and timing: A systematic analysis of clinical guidelines. 61
31285166 2020
25
Fetal lower urinary tract obstruction: What should we tell the prospective parents? 61
32065667 2020
26
Histologic chorioamnionitis concomitant placental abruption and its effects on pregnancy outcome. 61
32421533 2020
27
Identification of a 6-month-old baby with a combination of WAGR and Potocki-Shaffer contiguous deletion syndromes by SNP array testing. 61
32446308 2020
28
Effect of coffee consumption on fetal renal artery blood flow and amniotic fluid volume in third trimester of pregnancy. 61
32494265 2020
29
False diagnosis of small for gestational age and macrosomia - clinical and sonographic predictors. 61
32429707 2020
30
The effect of fetal weight on the accuracy of sonographic weight estimation among women with diabetes. 61
32441174 2020
31
The changing situation about maternal age, risk factors and pregnancy outcomes after the two-child policy: a retrospective cohort study. 61
32312075 2020
32
Decision-to-delivery interval of emergency cesarean section in Uganda: a retrospective cohort study. 61
32460720 2020
33
Diagnosis of Persistent Cloaca by Ultrasonography and MRI: A Case Report. 61
32381998 2020
34
Does Fetal Pulmonary Venous Flow Impedance Increase in Pregnancies With Placental Insufficiency-Related Oligohydramnios in the Third Trimester? 61
31705722 2020
35
Marginal placental cord insertion: the need for follow up? 61
32397941 2020
36
Fetal umbilical-systemic shunt with a positive issue. 61
31760176 2020
37
Risk factors for perinatal arterial ischaemic stroke: a large case-control study. 61
31489622 2020
38
Notice of Retraction: "Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial" (Maher MA, Sayyed TM, and Elkhouly N). 61
32150003 2020
39
Adverse perinatal outcomes in 665,244 term and post-term deliveries-a Norwegian population-based study. 61
32146227 2020
40
MR imaging of the fetal heart. 61
31190452 2020
41
Rare manifestations of Potter Sequence: A Case Report. 61
32347825 2020
42
Postnatal serum creatinine is elevated in preterm infants with PPROM-induced anhydramnios. 61
32278744 2020
43
Atrial septal aneurysm in pregnancy: echocardiography and obstetric outcomes. 61
32134736 2020
44
The effect of maternal position on fetal middle cerebral artery Doppler indices and its association with adverse perinatal outcomes: a pilot study. 61
32229676 2020
45
Neonatal outcomes following previable prelabour rupture of membranes before 23 weeks of gestation- a retrospective cohort study. 61
32224534 2020
46
Antenatal interventions based upon fetal surveillance of the daily opioid-exposed fetus: a descriptive analysis. 61
30078349 2020
47
A comparison of risk factors for breech presentation in preterm and term labor: a nationwide, population-based case-control study. 61
31741046 2020
48
Value of routine ultrasound examination at 35-37 weeks' gestation in diagnosis of non-cephalic presentation. 61
31671470 2020
49
Altered proteomics profile in the amnion of patients with oligohydramnios. 61
32109340 2020
50
Accuracy of the Ultrasound Estimate of the Amniotic Fluid Volume (Amniotic Fluid Index and Single Deepest Pocket) to Identify Actual Low, Normal, and High Amniotic Fluid Volumes as Determined by Quantile Regression. 61
31423632 2020
51
Second-Trimester Ultrasound-Measured Umbilical Cord Insertion-to-Placental Edge Distance: Determining an Outcome-Based Threshold for Identifying Marginal Cord Insertions. 61
31432561 2020
52
Predictive factors for intensive birth resuscitation in a developing-country: a 5-year, single-center study. 61
29973079 2020
53
Predictors of perinatal outcome in early-onset fetal growth restriction: A study from an emerging economy country. 61
31674030 2020
54
Risk Factors for Preterm Birth following Open Fetal Myelomeningocele Repair: Results from a Prospective Cohort. 61
31104051 2020
55
Open Intrauterine Fetal Myelomeningocele Repair: Changes in the Surgical Procedure and Perinatal Complications during the First 8 Years of Experience at a Single Center. 61
31801139 2020
56
Understanding Factors Leading to Primary Cesarean Section and Vaginal Birth After Cesarean Delivery in the Friuli-Venezia Giulia Region (North-Eastern Italy), 2005-2015. 61
31941963 2020
57
Periodontal condition is associated with adverse perinatal outcomes and premature rupture of membranes in low-income pregnant women in Bogota, Colombia: a case-control study. 61
29852806 2020
58
Reproductive health issues in female patients with beta-thalassaemia major: a narrative literature review. 61
31999213 2020
59
Perinatal features of Prader-Willi syndrome: a Chinese cohort of 134 patients. 61
31964399 2020
60
An Autopsy Case Report: Prune Belly Syndrome with Overlapping Presentation of Partial Urorectal Septum Malformation Sequence. 61
30632118 2020
61
The association between isolated oligohydramnios at term and placental pathology in correlation with pregnancy outcomes. 61
32056549 2020
62
Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. 61
32000798 2020
63
Updating the amniotic fluid index nomograms according to perinatal outcome. 61
30021504 2020
64
Current and future role of fetal cardiovascular MRI in the setting of fetal cardiac interventions. 61
31834624 2020
65
Secondary maternal-fetal consequences to electrical injury: A literature review. 61
32039774 2020
66
Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial. 61
31984652 2020
67
Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study. 61
31568057 2020
68
[Correlation between prenatal and postnatal observations in case of gastroschisis: Experience in a prenatal referral diagnosis center]. 61
31614232 2019
69
Outcome of posterior urethral valve in 64 children: a single center's 22-year experience. 61
30767491 2019
70
Nonossified cervical vertebrae in Wolf-Hirschhorn Syndrome: A case report. 61
31852098 2019
71
A Systematic Evaluation of Hospital Performance of Childbirth Delivery Modes and Associated Factors in the Friuli Venezia Giulia Region (North-Eastern Italy), 2005-2015. 61
31857615 2019
72
Maternal and Neonatal Outcomes among Obese Pregnant Women in King Abdulaziz University Hospital: A Retrospective Single-Center Medical Record Review. 61
32082014 2019
73
Factors associated with neonatal outcomes in preterm prelabor rupture of membranes after cervical cerclage. 61
31529463 2019
74
Antepartum and intrapartum risk factors for neonatal hypoxic-ischemic encephalopathy: a systematic review with meta-analysis. 61
31567446 2019
75
Amniotic fluid volume at presentation with early preterm prelabor rupture of membranes and association with severe neonatal respiratory morbidity. 61
30834608 2019
76
Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third-trimester paracetamol use: evaluation of the German Embryotox cohort. 61
31310697 2019
77
Prenatal exposure to isolated amniotic fluid disorders and the risk for long-term cardiovascular morbidity in the offspring. 61
31876194 2019
78
The association between pregnancies complicated with isolated polyhydramnios or oligohydramnios and offspring long-term gastrointestinal morbidity. 61
31642947 2019
79
Microarray findings in pregnancies with oligohydramnios - a retrospective cohort study and literature review. 61
31811807 2019
80
[INDUCTION OF LABOR AT 39 WEEKS OF GESTATION VERSUS EXPECTANT MANAGEMENT]. 61
31823535 2019
81
Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital. 61
29792056 2019
82
Risk factors for reduced fetal movements in pregnancy: A systematic review and meta-analysis. 61
31677496 2019
83
Prenatal Diagnosis of Autosomal Recessive Renal Tubular Dysgenesis with Anhydramnios Caused by a Mutation in the AGT Gene. 61
31718018 2019
84
The association between polyhydramnios and CMV infection - retrospective cohort study. 61
31698981 2019
85
Isolated oligohydramnios and long-term neurological morbidity of the offspring. 61
31755400 2019
86
Doppler Indices and Notching Assessment of Uterine Artery Between the 19th and 22nd Week of Pregnancy in the Prediction of Pregnancy Outcome. 61
31662556 2019
87
[ISOLATED OLIGOHYDRAMNIOS - THE DILEMMA OF PROPER MANAGEMENT]. 61
31721516 2019
88
Detection of a familial 1q21.1 microdeletion and concomitant CHD1L mutation in a fetus with oligohydramnios and bilateral renal dysplasia on prenatal ultrasound. 61
31759543 2019
89
Diagnostic utility of maximum vertical pocket versus amniotic fluid index in assessing amniotic fluid volume for the prediction of adverse maternal and fetal outcomes: a systematic review and meta-analysis. 61
31709861 2019
90
Maternal and obstetric complications in fetal surgery for prenatal myelomeningocele repair: a systematic review. 61
31574465 2019
91
Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy. 61
30977189 2019
92
Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review. 61
31273431 2019
93
Dichorionic pregnancy complicated by a twin-to-twin transfusion syndrome. 61
31666254 2019
94
Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction. 61
31723454 2019
95
Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review. 61
31422459 2019
96
Amniotic epithelial cells damage by oxidative stress in cases of diffuse chorioamniotic hemosiderosis. 61
31381226 2019
97
Segmental villous mineralization: A placental feature of fetal vascular malperfusion. 61
31358342 2019
98
Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article). 61
31577749 2019
99
Hyperemesis gravidarum causing Wernicke-Korsakoff syndrome: A rare complication. 61
31215137 2019
100
Effect of viral load on pregnancy outcomes in chronic hepatitis B infection. 61
31332897 2019
101
Two infants with bilateral renal agenesis who were bridged by chronic peritoneal dialysis to kidney transplantation. 61
31259459 2019
102
Oligohydramnios: should it be considered a risk factor for developmental dysplasia of the hip? 61
30839361 2019
103
Clinical factors in patients with congenital muscular torticollis treated with surgical resection. 61
31550745 2019
104
Fetal renal blood flow velocimetry and cerebro-placental ratio in patients with isolated oligohydramnios. 61
31176048 2019
105
Mosaic trisomy 22 at amniocentesis: Prenatal diagnosis and literature review. 61
31542095 2019
106
Long term follow-up in a patient with prune-belly syndrome - a care compliant case report. 61
31415370 2019
107
Prenatal detection of isolated bilateral hyperechogenic kidneys: Etiologies and outcomes. 61
30650191 2019
108
Urinary bladder agenesis and renal hypoplasia potentially related to in utero Zika virus infection. 61
31129423 2019
109
Comparative analysis of Insulin-like growth factor binding protein-1, placental alpha-microglobulin-1, phenol and pH for the diagnosis of preterm premature rupture of membranes between 20 and 36 weeks. 61
31099162 2019
110
Expression of Concern: Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial. 61
31348220 2019
111
Induction of labor in cases of late preterm isolated oligohydramnios: is it justified? 61
29343146 2019
112
Congenital urinary tract obstruction. 61
30819578 2019
113
Is Amniotic Fluid Level a Predictor for Syndromic Diagnosis in Robin Sequence? 61
30453768 2019
114
A case report of Turner syndrome associated with fetal nuchal cystic hygroma and bilateral syndactyly of the hands and feet. 61
31319890 2019
115
A case of post-splenectomy transfusion-dependent homozygous beta-thalassemia major complicated with myocardial siderosis and osteoporosis and usage of iron-chelating therapy with deferiprone in pregnancy. 61
31301670 2019
116
Fetomaternal Outcome In Women With Oligohydramnios Induced With Misoprostol. 61
31535516 2019
117
Brucellosis in pregnancy: results of multicenter ID-IRI study. 61
30989418 2019
118
Fetal brain hemodynamics in pregnancies at term: correlation with gestational age, birthweight and clinical outcome. 61
31288578 2019
119
Mortality Rate-Dependent Variations in the Timing and Causes of Death in Extremely Preterm Infants Born at 23-24 Weeks' Gestation. 61
31013260 2019
120
A contemporary amniotic fluid volume chart for the United States: The NICHD Fetal Growth Studies-Singletons. 61
30790566 2019
121
Association between Cervical Dysplasia and Adverse Pregnancy Outcomes. 61
31167238 2019
122
Evaluation of cord blood creatine kinase (CK), cardiac troponin T (cTnT), N-terminal-pro-B-type natriuretic peptide (NT-proBNP), and s100B levels in nonreassuring foetal heart rate. 61
31195859 2019
123
A clinical scoring system to predict the need for extensive resuscitation at birth in very low birth weight infants. 61
31200679 2019
124
Oligohydramnios is an independent risk factor for perinatal morbidity among women with pre-eclampsia who delivered preterm. 61
29237307 2019
125
Effect of Oligohydramnios on Fetal Heart Rate Patterns during Term Labor Induction. 61
30372774 2019
126
Predictors of a successful external cephalic version: A population-based study of Washington state births. 61
30150151 2019
127
Immediate perinatal outcomes of postterm deliveries. 61
29301466 2019
128
Birth Outcomes and Disease Activity During Pregnancy in a Prospective Cohort of Women With Psoriatic Arthritis and Ankylosing Spondylitis. 61
31074583 2019
129
Update on the Prenatal Diagnosis and Outcomes of Fetal Bilateral Renal Agenesis. 61
31098643 2019
130
CD15 as a marker of fetoplacental endothelial immaturity in IUGR placentas. 61
29251202 2019
131
Preterm birth: seven-year retrospective study in a single centre population. 61
30971310 2019
132
Prolonged early antenatal indomethacin exposure is safe for fetus and neonate. 61
30905227 2019
133
Renal tubular dysgenesis and microcolon, a novel association. Report of three cases. 61
30071301 2019
134
Relationship Between Torticollis and Gastroesophageal Reflux Disorder in Infants. 61
30865145 2019
135
A Comparison of Early Versus Late Prenatal Magnetic Resonance Imaging in the Diagnosis of Cleft Palate. 61
30855394 2019
136
Associations between risk factors and developmental dysplasia of the hip and ultrasonographic hip type: a retrospective case control study. 61
30996740 2019
137
Antenatal staging of congenital lower urinary tract obstruction. 61
29978555 2019
138
Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy. 61
31056151 2019
139
Trends and risk factors of stillbirth in Taiwan 2006-2013: a population-based study. 61
30734865 2019
140
[Body weight and gestational outcomes in women with high normotension during pregnancy]. 61
31309755 2019
141
Primary Sjögren's syndrome and pregnancy: A report of 18 cases. 61
28844688 2019
142
Prenatal findings and molecular cytogenetic analyses of a de novo interstitial deletion of 1q23.3 encompassing PBX1 gene. 61
30910156 2019
143
Effect of oligohydramnios on the accuracy of sonographic foetal weight estimation in at term pregnancies. 61
30910153 2019
144
Induction of labor methods in isolated term oligohydramnios. 61
30730010 2019
145
Characterization of Perinatal Risk Factors and Complications Associated With Nonsyndromic Craniosynostosis. 61
30358747 2019
146
How Well Do the Popular Ultrasonic Techniques Estimate Amniotic Fluid Volume and Diagnose Oligohydramnios, in Fact? 61
30601443 2019
147
Prevalence of Cesarean Section and Its Indications in A Tertiary Care Hospital. 61
31477935 2019
148
Use of plastic wound retractor at hysterotomy site in prenatal repair of myelomeningocele: a new technique. 61
30616410 2019
149
Vitamin D status in pregnant women visiting a tertiary care center of North Eastern India. 61
30984638 2019
150
Effects of induction of labor prior to post-term in low-risk pregnancies: a systematic review. 61
30299344 2019
151
Do the risk factors for developmental dysplasia of the hip differ according to gender? A look from another perspective. 61
30069945 2019
152
Midtrimester isolated oligohydramnios in monochorionic diamniotic multiple gestations. 61
28965437 2019
153
Outcomes in fetuses diagnosed with megacystis: Systematic review and meta-analysis. 61
30594021 2019
154
Amnioinfusion for variable decelerations caused by umbilical cord compression without oligohydramnios but with the sandwich sign as an early marker of deterioration. 61
30246578 2019
155
Management and evaluation of pregnant women with Takayasu arteritis. 61
30302544 2019
156
Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes. 61
30856108 2019
157
Prenatal imaging features suggestive of liver gestational allo immune disease. 61
30465890 2019
158
Fetal and Neonatal Circulatory Disorders in Twin to Twin Transfusion Syndrome (The Secondary Publication). 61
31484880 2019
159
A Case of Type I Sirenomelia Complicated by Severe Oligohydramnios in the First Trimester. 61
31956455 2019
160
Diagnosis, Phenotype, and Molecular Genetics of Congenital Analbuminemia. 61
31057599 2019
161
Epidemiological profile of patients with preterm premature rupture of membranes at a tertiary hospital in São Paulo, Brazil. 61
31644662 2019
162
The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis. 61
31339910 2019
163
Early and Severe Polycystic Kidney Disease and Related Ciliopathies: An Emerging Field of Interest. 61
30359986 2019
164
Polycystic kidney disease in neonates and infants. Clinical diagnosis and histopathological correlation. 61
31658328 2019
165
Cloacal Anomalies in Monoamniotic, Monochorionic Twins with Complete Urinary Tract Obstruction. 61
30540986 2019
166
Survival Rate without Brain Abnormalities on Postnatal Ultrasonography among Monochorionic Twins after Fetoscopic Laser Photocoagulation for Selective Intrauterine Growth Restriction with Concomitant Oligohydramnios. 61
29462812 2019
167
The Relationship between the Fetal Volume-Corrected Renal Artery Pulsatility Index and Amniotic Fluid Volume. 61
30300895 2019
168
Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial. 61
30531572 2019
169
Association of cord blood ischemia-modified albumin level with abnormal foetal Doppler parameters in intrauterine growth-restricted foetuses. 61
30691329 2019
170
Massive Subchorionic Thrombohematoma (Breus' Mole) Associated with Fetal Growth Restriction, Oligohydramnios, and Intrauterine Fetal Death. 61
31183232 2019
171
In utero Partial Exchange Transfusion Combined with in utero Blood Transfusion for Prenatal Management of Twin Anemia-Polycythemia Sequence. 61
29533957 2019
172
Galloway-Mowat syndrome in Taiwan: OSGEP mutation and unique clinical phenotype. 61
30558655 2018
173
Exome sequencing identifies novel ACE splice-site variant in a fetus with renal tubular dysgenesis. 61
30058238 2018
174
The efficacy of inhaled nitric oxide treatment in premature infants with acute pulmonary hypertension. 61
30205295 2018
175
Sirenomelia in twin pregnancy: A case report and literature review. 61
30572488 2018
176
Risk factors and outcomes of early pulmonary hypertension in preterm infants. 61
28783986 2018
177
CERVICAL RIPENING BALLOON AS A METHOD OF PREINDUCTION - ONE CENTER STUDY. 61
31168214 2018
178
Perinatal outcomes in uncomplicated late preterm pregnancies with borderline oligohydramnios. 61
28782398 2018
179
Serial Third-Trimester Ultrasonography Compared With Routine Care in Uncomplicated Pregnancies: A Randomized Controlled Trial. 61
30399092 2018
180
Magnetic resonance imaging for evaluation of foetal multicystic dysplastic kidney. 61
30396644 2018
181
Fetal stroke and cerebrovascular disease: Advances in understanding from lenticulostriate and venous imaging, alloimmune thrombocytopaenia and monochorionic twins. 61
30467085 2018
182
Effect of Maternal Body Mass Index and Amniotic Fluid Index on the Accuracy of Sonographic Estimation of Fetal Weight in Late Gestation. 61
29320802 2018
183
Maternal and perinatal outcomes of expectant treatment of severe preeclampsia 61
30521741 2018
184
Outcomes of Women Delivering at Very Advanced Maternal Age. 61
30016194 2018
185
Outcomes in oligohydramnios: the role of etiology in predicting pulmonary morbidity/mortality. 61
29924737 2018
186
Prenatal diagnosis of funisitis: two case reports. 61
29396737 2018
187
Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report. 61
30294557 2018
188
Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR. 61
30287750 2018
189
Hypercoiled cord can cause a reversible abnormal Doppler in ductus venosus in cases of fetal growth restriction. 61
29974562 2018
190
Perinatal Outcomes of Fetal Lower Urinary Tract Obstruction After Vesicoamniotic Shunting Using a Double-Basket Catheter. 61
29498072 2018
191
Use of pertuzumab and trastuzumab during pregnancy. 61
30110018 2018
192
Association analysis between four vitamin D receptor gene polymorphisms and developmental dysplasia of the hip. 61
30262704 2018
193
Altered biomechanical stimulation of the developing hip joint in presence of hip dysplasia risk factors. 61
30037582 2018
194
Prevalence and Indications of Cesarean Section in a Community Hospital of Western Region of Nepal. 61
31065123 2018
195
Prenatal renal parenchymal area as a predictor of early end-stage renal disease in children with vesicoamniotic shunting for lower urinary tract obstruction. 61
30093259 2018
196
Early transplantation into a vesicostomy: a safe approach for managing patients with severe obstructive lesions who are not candidates for bladder augmentation. 61
30228092 2018
197
Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease. 61
29753540 2018
198
Pregnancy outcomes in women with non-transfusion dependent thalassaemia (NTDT): A haematology centre experience. 61
30173232 2018
199
Role of Autopsy in Elective Termination of Pregnancy for Fetal Anomaly (ETOPFA): A Study from a Tertiary Care Hospital in India. 61
30188228 2018
200
Preterm Preeclampsia with Severe Features: Composite Maternal and Neonatal Morbidities Associated with Fetal Growth Restriction. 61
29298455 2018
201
Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm. 61
29426264 2018
202
Early Accreta and Uterine Rupture in the Second Trimester. 61
30186710 2018
203
A family segregating lethal neonatal coenzyme Q10 deficiency caused by mutations in COQ9. 61
29560582 2018
204
Five successful pregnancies with antenatal anakinra exposure. 61
29660063 2018
205
A Novel Approach to Serial Amnioinfusion in a Case of Premature Rupture of Membranes Near the Limit of Viability. 61
30250757 2018
206
Gestational weight gain and weight loss among women with gestational diabetes mellitus. 61
29689321 2018
207
In utero spontaneous bladder rupture in a fetus with posterior urethral valve: A case report of prenatal diagnosis and management. 61
29673009 2018
208
Prenatal diagnosis of Wolf-Hirschhorn syndrome: Ultrasonography and molecular karyotyping results. 61
29626710 2018
209
Ultrasonographic prediction of antepartum deterioration of growth-restricted fetuses after late preterm. 61
29607579 2018
210
Evaluation of the fetal abdomen by magnetic resonance imaging. Part 2: abdominal wall defects and tumors. 61
29991841 2018
211
Fetal Urinary Tract Anomalies: Review of Pathophysiology, Imaging, and Management. 61
29446682 2018
212
Fetoscopic laser photocoagulation for twin-twin transfusion syndrome. 61
29436080 2018
213
Causes of renal oligohydramnios: impact on prenatal counseling and postnatal outcome. 61
29128922 2018
214
Prenatal parental decision-making and postnatal outcome in renal oligohydramnios. 61
29075889 2018
215
Placental examination in nonmacerated stillbirth versus neonatal mortality. 61
28915123 2018
216
Management and Outcome of Reduced Fetal Movements-is Ultrasound Necessary? 61
29276160 2018
217
An unusual presentation of urethral duplication presenting with chronic bladder retention, left scrotal transposition and left renal agenesis. 61
29064654 2018
218
Maternal Body Mass Index and Amniotic Fluid Index in Late Gestation. 61
28851017 2018
219
Predisposing Factors and Outcome of Malpresentations in an Institute. 61
30381763 2018
220
Causes and risk factors for singleton stillbirth in Japan: Analysis of a nationwide perinatal database, 2013-2014. 61
29515220 2018
221
Evaluation of the fetal abdomen by magnetic resonance imaging. Part 1: malformations of the abdominal cavity. 61
29743740 2018
222
Polyhydramnios Affecting a Recipient-like Twin: Risk of Progression to Twin-Twin Transfusion Syndrome and Outcomes. 61
29287298 2018
223
[Single Deepest Vertical Pocket or Amniotic Fluid Index as Evaluation Test for Predicting Adverse Pregnancy Outcome (SAFE trial): A Multicenter, Open-Label, Randomized Controlled Trial]. 61
29499583 2018
224
Is pregnancy associated plasma protein-A (PAPP-A) a marker for adverse perinatal outcomes in preterm isolated oligohydramnios cases? 61
29458908 2018
225
[Contribution of ultrasound pulmonary ratio in pre-viable premature ruptures of membranes]. 61
29287971 2018
226
Successful treatment of severe arterial hypotension and anuria in a preterm infant with renal tubular dysgenesis- a case report. 61
30598831 2018
227
Natural History of Fetal Lower Urinary Tract Obstruction with Normal Amniotic Fluid Volume at Initial Diagnosis. 61
28700992 2018
228
Inhaled Nitric Oxide in Preterm Neonates with Refractory Hypoxemia Associated to Oligohydramnios. 61
29046161 2018
229
Evaluation of the relation between placental weight and placental weight to foetal weight ratio and the causes of stillbirth: a retrospective comparative study. 61
28971718 2018
230
Fetal Sirenomelia Associated with an Abdominal Cyst Originating from a Saccular Cloaca. 61
29707395 2018
231
Spontaneous Septostomy in a Twin Pregnancy Causing Fatal Amniotic Band Syndrome. 61
30693129 2018
232
An Account of Labor and Birth Following a High-Risk Pregnancy That Ended in Induction of Labor at 37 Weeks: An Acknowledgment of When Option B Can Still Lead to a Positive Birth Experience. 61
30863003 2018
233
A case of gestational central diabetes insipidus with oligohydramnios. 61
28764595 2018
234
Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy. 61
30135348 2018
235
Expectant management of pregnancies complicated by fetal growth restriction without any evidence of placental dysfunction at term: Comparison with routine labor induction. 61
28892225 2018
236
[Uterine rupture in patients with healthy uterus: misoprostol complication (case study and literature review)]. 61
31447981 2018
237
Does ovulation induction and intrauterine insemination affect perinatal outcomes in singletons? 61
27558286 2018
238
Congenital cystic adenomatous malformation: a case report and a literature review. 61
30210243 2018
239
Perinatal Diagnosis, Management, and Follow-up of Cystic Renal Diseases: A Clinical Practice Recommendation With Systematic Literature Reviews. 61
29181500 2018
240
Proximal Deletion of 6q Overlapping with Toriello-Carey Facial Phenotype: Prenatal Findings, Clinical Course, Differential Diagnosis, and Review. 61
29456478 2017
241
Prenatal diagnosis of sirenomelia with anencephaly and craniorachischisis totalis: A case report study. 61
29390297 2017
242
Successful Pregnancy Outcome in Recurrent Ovarian Cancer in a 26 Year Old: A Case Report. 61
30288170 2017
243
Redness discordance in monochorionic twin placentas: Correlation with clinical and placental findings. 61
29208240 2017
244
Effect of fetal gender on induction of labor failure rates. 61
27936988 2017
245
Giant fetal hydrometrocolpos associated with cloacal anomaly causing postnatal respiratory distress. 61
28707775 2017
246
Association between cord blood cystatin C levels and early mortality of neonates with congenital abnormalities of the kidney and urinary tract: a single-center, retrospective cohort study. 61
28681080 2017
247
Maternal olmesartan exposure causing neonatal failure. 61
29092961 2017
248
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial. 61
29064958 2017
249
Parameters Associated with Adverse Fetal Outcomes in Parvovirus B19 Congenital Infection. 61
28946175 2017
250
Lower urinary tract obstruction: fetal intervention based on prenatal staging. 61
28730376 2017
251
De novo chromosome 7q36.1q36.2 triplication in a child with developmental delay, growth failure, distinctive facial features, and multiple congenital anomalies: a case report. 61
29061174 2017
252
Immediate neonatal outcomes of preterm infants born to mothers with preterm pre-labour rupture of membranes. 61
29434061 2017
253
Prenatal detection of megacystis: not always an adverse prognostic factor. Experience in 25 consecutive cases in a tertiary referral center, with complete neonatal outcome and follow-up. 61
28495235 2017
254
Are Major Depression and Generalized Anxiety Disorder Associated With Oligohydramnios in Pregnant Women? A Case-Control Study. 61
27357862 2017
255
Large Subchorionic Hematoma: Breus' Mole. 61
30065502 2017
256
Tanshinone IIA increases aquaporins expression in human amniotic epithelial WISH cells by stimulating GSK-3β phosphorylation. 61
27840100 2017
257
Extracorporeal Membrane Oxygenation for Neonates with Congenital Renal and Urological Anomalies and Pulmonary Hypoplasia: A Case Report and Review of the Extracorporeal Life Support Organization Registry. 61
31073446 2017
258
Can quantity of amniotic fluid reliably predict postnatal renal function in boys with posterior urethral valves: a decision curve analysis. 61
28753736 2017
259
Clinical investigation of chromosomal karyotype analysis in cells cultured from fetal bladder puncture liquid. 61
28962098 2017
260
Evaluation of Maternal and Perinatal Outcomes of Induction in Borderline Oligohydramnios at Term. 61
29207783 2017
261
Florid Intussusceptive-like Microvascular Dysangiogenesis in a Preterm Lung. 61
28812466 2017
262
Addition of Color Doppler Sonography for Detection of Amniotic Fluid Disturbances and Its Implications on Perinatal Outcomes. 61
28503847 2017
263
Diagnostic Approach to Pulmonary Hypertension in Premature Neonates. 61
28837121 2017
264
Femoral Hypoplasia with Unusual Facies Syndrome. 61
28969231 2017
265
Analysis of musculoskeletal dysmorphic abnormalities of 20 fetuses. 61
28760128 2017
266
Misdiagnosis of a cloacal exstrophy variant as urorectal septum malformation in a fetus by ultrasound: A case report. 61
28810634 2017
267
Major determinants of survival and length of stay in the neonatal intensive care unit of newborns from women with premature preterm rupture of membranes. 61
27624140 2017
268
The importance of declining insulin requirements during pregnancy in patients with pre-gestational gestational diabetes mellitus. 61
28628847 2017
269
Prenatal, perinatal and neonatal risk factors for perinatal arterial ischaemic stroke: a systematic review and meta-analysis. 61
28646492 2017
270
Pregnancy Outcomes in Isolated Oligohydramnios during Second Trimester: A Case Series. 61
28969220 2017
271
[Mesenteric edema as a prenatal ultrasound sign of poor prognosis in gastroschisis]. 61
29043689 2017
272
MRI findings of chronic abruption-oligohydramnios sequence (CAOS): report of three cases. 61
28396921 2017
273
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial. 61
28644321 2017
274
[Risk factors associated with preterm birth in a second level hospital]. 61
28591495 2017
275
Predicting postnatal renal function of prenatally detected posterior urethral valves using fetal diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient determination. 61
28453880 2017
276
Admission Test and Pregnancy Outcome. 61
28761202 2017
277
Risk Factors for Development of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis. 61
28188008 2017
278
Oligohydramnios compromises lung cells size and interferes with epithelial-endothelial development. 61
28152278 2017
279
The Effect of the Amniotic Fluid Index on the Accuracy of Ultrasonographic-Estimated Fetal Weight. 61
28221239 2017
280
Posterior urethral valves: Impact of low birth weight and preterm delivery on the final renal outcome. 61
29071146 2017
281
Maternal and perinatal characteristics of small-for-gestational-age newborns: Ten-year experience of a single center. 61
28490415 2017
282
Variable presentation of Fraser syndrome in two fetuses and a novel mutation in FRAS1. 61
27624506 2017
283
[Macroscopic description of placental vascular anastomoses after dye injection for the comprehension of monochorionic pregnancy complications]. 61
28479073 2017
284
Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis. 61
27270878 2017
285
Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach? 61
27627792 2017
286
Fetal Nasal Bone Length as a Novel Marker for Prediction of Adverse Perinatal Outcomes in the First-Trimester of Pregnancy. 61
28418339 2017
287
Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. 61
27062200 2017
288
Outcome of Antenatally Presenting Posterior Urethral Valves (PUV) in Children. 61
28031548 2017
289
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial. 61
28277352 2017
290
Breech presentation at term and associated obstetric risks factors-a nationwide population based cohort study. 61
28176014 2017
291
Risk factors associated with adverse perinatal outcome in planned vaginal breech labors at term: a retrospective population-based case-control study. 61
28320344 2017
292
Prostaglandin E2 induction of labor and cervical ripening for term isolated oligohydramnios in pregnant women with Bishop score ≤ 5. 61
27745800 2017
293
Danshen extract regulates the expression of aquaporin 3 in human amniotic epithelial cells. 61
28199196 2017
294
Sonography interval and the diagnosis of twin-twin transfusion syndrome. 61
27124662 2017
295
Impact of fetal counseling on outcome of antenatal congenital surgical anomalies. 61
27864598 2017
296
Fetal megacystis: A systematic review. 61
27889224 2017
297
Pulmonary Hypoplasia Induced by Oligohydramnios: Findings from Animal Models and a Population-Based Study. 61
27324123 2017
298
Novel Col12A1 variant expands the clinical picture of congenital myopathies with extracellular matrix defects. 61
27348394 2017
299
Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction. 61
27049175 2017
300
Doppler velocimetry and adverse outcome in labor induction for late IUGR. 61
27020201 2017
301
Risk of malignant childhood germ cell tumors in relation to demographic, gestational, and perinatal characteristics. 61
28013088 2017
302
Postoperative disseminated intravascular coagulation in a pregnant patient with Blue Rubber Bleb Nevus Syndrome presenting with acute intestinal obstruction: Case report and literature review. 61
28858742 2017
303
Report of a Triploid Fetus Identified in a Pregnancy with Oligohydramnios. 61
28459702 2017
304
Combined Respiratory Chain Deficiency and UQCC2 Mutations in Neonatal Encephalomyopathy: Defective Supercomplex Assembly in Complex III Deficiencies. 61
28804536 2017
305
Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome? 61
28727133 2017
306
Epidemiology and Related Risk Factors of Preterm Labor as an obstetrics emergency. 61
28286810 2017
307
Induction of Labor in Women with Oligohydramnios: Misoprostol Compared with Prostaglandin E2. 61
27398704 2017
308
Serial amnioinfusions for fetal pulmonary palliation in fetuses with renal failure. 61
26978650 2017
309
Ultrasound guided balloon catheterisation: a new method of fetal lower urinary tract obstruction management. 61
28580571 2017
310
Use of an Amnioport to Maintain Amniotic Fluid Volume in Fetuses with Oligohydramnios Secondary to Lower Urinary Tract Obstruction or Fetal Renal Anomalies. 61
27287190 2017
311
[The finding of isolated oligohydramnios after 37th week of gestation and its association with perinatal outcome]. 61
29020781 2017
312
Adverse Pregnancy Outcomes of Patients with History of First-Trimester Recurrent Spontaneous Abortion. 61
28798930 2017
313
Antenatal fetal surveillance "Assessment of the AFV". 61
27756534 2017
314
Linking expression of aquaporin 3 to activation of JNK pathway. 61
27814615 2017
315
Estimated Fetal Weight: Comparison of Clinical Versus Ultrasound Estimate. 61
28714492 2017
316
Association between perinatal hypoxic-ischemia and periventricular leukomalacia in preterm infants: A systematic review and meta-analysis. 61
28931047 2017
317
Clinical characteristics and pregnancy outcomes of Syrian refugees: a case-control study in a tertiary care hospital in Istanbul, Turkey. 61
27589848 2017
318
Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines? 61
28255521 2017
319
Placental Chorangiosis: Increased Risk for Cesarean Section. 61
28607782 2017
320
Meconium-Stained Amniotic Fluid and Neonatal Morbidity in Low-Risk Pregnancies at Term: The Effect of Gestational Age. 61
27367282 2017
321
Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh. 61
29155840 2017
322
The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. 61
27496687 2016
323
Are ultrasound renal aspects associated with urinary biochemistry in fetuses with lower urinary tract obstruction? 61
27862070 2016
324
Renal tubular dysgenesis: antenatal ultrasound scanning and molecular investigations in a Saudi Arabian family. 61
27994858 2016
325
Pulmonary Arterial Hypertension after Ibuprofen Treatment for Patent Ductus Arteriosus in Very Low Birth Weight Infants. 61
27692860 2016
326
Fraser syndrome: features suggestive of prenatal diagnosis in a review of 38 cases. 61
27859469 2016
327
Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey. 61
26887856 2016
328
Oligohydramnios and growth restriction do not portend worse prognosis in gastroschisis pregnancies. 61
26932657 2016
329
Perinatal outcome of monochorionic diamniotic twin pregnancies complicated with isolated amniotic fluid volume abnormality of one twin less than 26 weeks of gestation. 61
27557852 2016
330
Bladder agenesis, ectopic ureters and a multicystic dysplastic horseshoe kidney in one twin newborn with normal amniotic fluid index in utero. 61
27932430 2016
331
Renal failure from birth-AKI or CKD? Questions. 61
26891726 2016
332
Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis. 61
28002314 2016
333
Gestational Alloimmune Liver Disease: A Devastating Condition Preventable With Maternal Intravenous Immunoglobulin. 61
27741190 2016
334
Evaluation of the maternal and fetal risk factors associated with neonatal care unit hospitalization time. 61
26857257 2016
335
Significance of oligohydramnios in preterm small-for-gestational-age infants for outcome at 18 months of age. 61
27352940 2016
336
Intrauterine vesicoamniotic shunting for fetal megacystis. 61
27394921 2016
337
A randomized controlled study of the efficacy of 4 weeks of supplementation with ω-3 polyunsaturated fatty acids in cases of unexplained oligohydramnios. 61
27559716 2016
338
Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report. 61
27821175 2016
339
Use of complementary and alternative medicine in pregnancy and its impact on obstetric outcome. 61
27863606 2016
340
Prenatal sonographic diagnosis of urorectal septum malformation sequence and chromosomal microarray analysis: A case report and review of the literature. 61
27828853 2016
341
Use of Intracervical Foley Catheter for Induction of Labour in Cases of Previous Caesarean Section: Experience of a single tertiary centre in Oman. 61
28003890 2016
342
Predicting success of labor induction in singleton term pregnancies by combining maternal and ultrasound variables. 61
26742573 2016
343
Types and Outcome of Fetal Urinary Anomalies in Low Resource Setting Countries: A Retrospective Study. 61
27486275 2016
344
Impact of HIGH BMI on Pregnancy: Maternal and Foetal Outcome. 61
27651602 2016
345
Contemporary outcomes of sickle cell disease in pregnancy. 61
27242200 2016
346
Hyperechogenic kidneys and polyhydramnios associated with HNF1B gene mutation. 61
27286685 2016
347
Perinatal outcomes with isolated oligohydramnios at term pregnancy. 61
26506098 2016
348
Role of l-Arginine in Oligohydramnios. 61
27651617 2016
349
Amniotic fluid volume: Rapid MR-based assessment at 28-32 weeks gestation. 61
26792428 2016
350
Fetal bladder outlet obstruction: Embryopathology, in utero intervention and outcome. 61
27570093 2016
351
[Female Preterm Monozygotic Twins Discordant for Fetal Megacystis due to Cloacal Dysgenesis After Conception by Intracytoplasmatic Sperm Injection - Case Report and Review of Literature]. 61
27764886 2016
352
Maternal Serum Aneuploidy Screen and Adverse Pregnancy Outcomes. 61
27651593 2016
353
Uterine tachysystole in spontaneous labor at term. 61
27074823 2016
354
Ocular manifestations of X-linked dominant FAM58A mutation in toe syndactyly, telecanthus, anogenital, and renal malformations ('STAR') syndrome. 61
26882209 2016
355
[Pregnancy outcome after preconceptional exposure to methotrexate for ectopic pregnancy]. 61
27203166 2016
356
[Influence of hypertension disorder complicating pregancy and its interaction with other factors on incidence of small for gestational age]. 61
27655579 2016
357
Obstetric outcomes of isolated oligohydramnios during early-term, full-term and late-term periods and determination of optimal timing of delivery. 61
27225520 2016
358
Obstetric Complications and Pregnancy Outcome Among Grand Multiparous Women. 61
30383944 2016
359
Procedure-related complications of open vs endoscopic fetal surgery for treatment of spina bifida in an era of intrauterine myelomeningocele repair: systematic review and meta-analysis. 61
26612040 2016
360
Accuracy of antenatal ultrasound signs in predicting the risk for bowel atresia in patients with gastroschisis. 61
27280540 2016
361
Is the diagnostic yield influenced by the indication for fetal autopsy? 61
27197608 2016
362
Erythroblastosis of the Donor Twin of Twin Anemia-Polycythemia Sequence. 61
27549671 2016
363
DNA copy number variants: A potentially useful predictor of early onset renal failure in boys with posterior urethral valves. 61
27160979 2016
364
Conservative Management and Planned Surgery for Periviable Advanced Extrauterine Abdominal Pregnancy with Favorable Outcome: Report of Two Cases. 61
27595049 2016
365
Atypical twin-to-twin transfusion syndrome: prevalence in a population undergoing fetoscopic laser ablation of communicating placental vessels. 61
26827875 2016
366
Epidemiological Risk Factors and Perinatal Outcomes of Congenital Anomalies. 61
27459392 2016
367
Prenatal sonographic features of triploidy at 12-16 weeks. 61
27135789 2016
368
Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants. 61
27225961 2016
369
[Prenatal care and risk factors associated with premature birth and low birth weight in the a capital in the Brazilian Northeast]. 61
27276545 2016
370
Prediction of adverse pregnancy outcomes using uterine artery Doppler imaging at 22-24 weeks of pregnancy: A North Indian experience. 61
28913097 2016
371
Nephronophthisis 61
27336129 2016
372
Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial. 61
26094600 2016
373
Infantile Respiratory Distress Syndrome and Its Probable Links With Parameters of the Maternal Patient History: A Forensic Case Report. 61
27049660 2016
374
Clustering and classical analysis of clinical and placental phenotypes in fetal growth restriction and constitutional fetal smallness. 61
27238719 2016
375
Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology. 61
26983702 2016
376
Outcome after prenatal diagnosis of congenital anomalies of the kidney and urinary tract. 61
26805407 2016
377
Evaluation of perinatal outcomes in pregnant women with preterm premature rupture of membranes. 61
27310552 2016
378
Risk Factors for Preterm Birth and Low Birth Weight Among Pregnant Indian Women: A Hospital-based Prospective Study. 61
27255075 2016
379
[Contribution of ultrasound signs for the prenatal diagnosis of posterior urethral valves: Experience of 3years at the maternity of the Bicêtre Hospital]. 61
25980903 2016
380
Neuroblastoma presenting with symptoms of epidural compression at birth: a case report. 61
27209026 2016
381
Hip Click in the Neonate: Should I Be Concerned? 61
27064468 2016
382
Association Between Isolated Single Umbilical Artery and Perinatal Outcomes: A Meta-Analysis. 61
27130891 2016
383
Lack of pharmacist-physician communication associated with nimesulide-induced oligohydramnios during pregnancy. 61
26951121 2016
384
Fetal Intra-Peritoneal Transfusion for the Management of Very Early Spontaneous Twin Anemia-Polycythemia Sequence in an Obese Patient With a Whole Anterior Placenta. 61
26996223 2016
385
Severe antenatally diagnosed renal disorders: background, prognosis and practical approach. 61
26081158 2016
386
[Case Report on Treatment of Metastatic Breast Cancer with Trastuzumab during Pregnancy]. 61
27111595 2016
387
The Association between N-terminal Pro-Brain Natriuretic Peptide Levels in the Umbilical Vein and Amniotic Fluid Volume Abnormalities. 61
27096950 2016
388
Fetus with Casamassima-Morton-Nance Syndrome and Limb-Body Wall Defect: Presentation of a Novel Association and Review of the Phenotype. 61
26367183 2016
389
Prenatal diagnosis of sirenomelia in the first trimester: A case report. 61
28913090 2016
390
Rapid Resolution of Polyhydramnios Foretells Circulatory Collapse for the Donor Twin in Feto-Fetal Transfusion Syndrome. 61
26932285 2016
391
Effect of Meconium-Stained Amniotic Fluid on Perinatal Complications in Low-Risk Pregnancies at Term. 61
26479168 2016
392
Breech presentation: its predictors and consequences. An analysis of the Hungarian Tauffer Obstetric Database (1996-2011). 61
26660231 2016
393
An Ashkenazi founder mutation in the PKHD1 gene. 61
26721323 2016
394
Accelerated acidosis in response to variable fetal heart rate decelerations in chronically hypoxic ovine fetuses. 61
26433172 2016
395
Polyhydramnios in Lrp4 knockout mice with bilateral kidney agenesis: Defects in the pathways of amniotic fluid clearance. 61
26847765 2016
396
Incidence and Risks of Congenital Anomalies of Kidney and Urinary Tract in Newborns: A Population-Based Case-Control Study in Taiwan. 61
26844492 2016
397
Sonographic markers associated with adverse neonatal outcomes among fetuses with gastroschisis: an 11-year, single-center review. 61
26454131 2016
398
Can Radiology Play a Role in Early Diagnosis of Dengue Fever? 61
27042608 2016
399
Ultrasonographic peculiarities of fetoplacental complex in pregnancy complicated by intrauterine infection. 61
28478410 2016
400
Ultrasonographic peculiarities of fetoplacental complex in pregnancy complicated by intrauterine infection. 61
27717929 2016
401
A review of Meckel-Gruber syndrome--incidence and outcome in the state of Qatar. 61
26333300 2016
402
Pierre Robin sequence: Subdivision, data, theories, and treatment - Part 1: History, subdivisions, and data. 61
27563603 2016
403
Pierre Robin sequence: Subdivision, data, theories, and treatment - Part 2: Syndromic and nonsyndromic Pierre Robin sequence. 61
27563604 2016
404
Pierre Robin sequence: Subdivision, data, theories, and treatment - Part 3: Prevailing controversial theories related to Pierre Robin sequence. 61
27563605 2016
405
Pierre Robin sequence: Subdivision, data, theories, and treatment - Part 4: Recommended management and treatment of Pierre Robin sequence and its application. 61
27563606 2016
406
Amniotic Band Syndrome, Perinatal Hospice, and Palliative Care versus Active Management. 61
28025631 2016
407
Cloacal dysgenesis sequence with bilateral renal agenesis and normal pulmonary development in twin pregnancy. 61
26791133 2016
408
Vojta method in the treatment of developmental hip dysplasia - a case report. 61
27578980 2016
409
ECHS1 Deficiency as a Cause of Severe Neonatal Lactic Acidosis. 61
26920905 2016
410
Arthrogryposis multiplex congenital - multidisciplinary care - including own experience. 61
27941188 2016
411
Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. 61
27158525 2016
412
A Rare Coexistence of Bilateral Congenital Wilms Tumor with Ductal Plate Malformation at Autopsy. 61
27054810 2016
413
Spectrum of Maternofetal Outcomes during Dengue Infection in Pregnancy: An Insight. 61
27069349 2016
414
Effects of Thyroid Peroxidase Antibody on Maternal and Neonatal Outcomes in Pregnant Women in an Iodine-Sufficient Area in China. 61
26884759 2016
415
Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature. 61
27672462 2016
416
What does fetal autopsy unmask in oligohydramnios? 61
26381033 2016
417
Survival of fetuses with severe oligohydramnios. 61
27328487 2016
418
Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. 61
26453266 2016
419
Sildenafil citrate for the management of fetal growth restriction and oligohydramnios. 61
27563258 2016
420
High Prevalence of Vitamin D Deficiency and Adverse Pregnancy Outcomes in Yazd, a Central Province of Iran. 61
26962481 2016
421
Isolated Oligohydramnios at Term as an Indication for Labor Induction: A Systematic Review and Meta-Analysis. 61
27160748 2016
422
Spontaneous Uterine Rupture in a Preterm Pregnancy following Myomectomy. 61
26925275 2016
423
Prenatal risk stratification of severe small-for-gestational-age infants: a Japanese multicenter study. 61
26043297 2016
424
Aquaporin 3 Expression Induced by Salvia Miltiorrhiza via ERK1/2 Signal Pathway in the Primary Human Amnion Epithelium Cells from Isolated Oligohydramnios. 61
26917259 2016
425
Antenatal Determinants of Long-Term Kidney Outcome in Boys with Posterior Urethral Valves. 61
26375276 2016
426
[Femoral hypoplasia-unusual facies syndrome: A case report]. 61
26455697 2016
427
The indication for induction of labor impacts the risk of cesarean delivery. 61
25483420 2016
428
Neonatal acute kidney injury following Valsartan exposure in utero: report of two cases. 61
27895448 2016
429
Minor anomalies in stillborn and second trimester miscarried fetuses. 61
26373818 2016
430
Factors Associated With Increased Risk of Clubfoot: A Norwegian National Cohort Analysis. 61
26539903 2015
431
Should we offer prenatal testing for 17q12 microdeletion syndrome to all cases with prenatally diagnosed echogenic kidneys? Prenatal findings in two families with 17q12 microdeletion syndrome and review of the literature. 61
26429400 2015
432
Prenatal diagnosis of sirenomelia by two-dimensional and three-dimensional skeletal imaging ultrasound. 61
26670448 2015
433
Extrafetal Findings on Fetal Magnetic Resonance Imaging: A Pictorial Essay. 61
26614136 2015
434
Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. 61
26318712 2015
435